Skip to content

RVMD

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$190.27
+0.82%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
42.61x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
15.65x
Price / sales
—
Price / cash flow
-33.34x

Enterprise value

Enterprise value
$37.5B
EV / sales
—
EV / EBITDA
-22.17x
EV / EBIT
-23.04x
Market cap
$40.8B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026